We are live on ! Find out more
FC

FORA Capital Portfolio holdings

AUM $1.36B
1-Year Est. Return 56.1%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+56.1%
3 Year Est. Return
+119.91%
5 Year Est. Return
+163.37%
10 Year Est. Return
AUM
$1.36B
AUM Growth
+$538M
Cap. Flow
+$603M
Cap. Flow %
44.21%
Top 10 Hldgs %
16.6%
Holding
636
New
225
Increased
124
Reduced
64
Closed
223

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$28.7M
2
B
Barrick Mining
B
+$26.1M
3
ORCL icon
Oracle
ORCL
+$23.3M
4
SOFI icon
SoFi Technologies
SOFI
+$19.6M
5
LMT icon
Lockheed Martin
LMT
+$18.8M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$20.2M
2
NFLX icon
Netflix
NFLX
+$13.9M
3
COST icon
Costco
COST
+$12.3M
4
TSM icon
TSMC
TSM
+$12.3M
5
GEV icon
GE Vernova
GEV
+$11.6M

Sector Composition

Rank Sector Weight
1 Technology 28.37%
2 Industrials 13.95%
3 Financials 13.85%
4 Communication Services 8.9%
5 Materials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AROC icon
176
Archrock
AROC
$6.33B
$1.67M 0.12%
+47,911
New +$1.53M
ITRI icon
177
Itron
ITRI
$3.73B
$1.65M 0.12%
+18,387
New +$1.77M
IVZ icon
178
Invesco
IVZ
$13.3B
$1.61M 0.12%
+66,449
New +$1.74M
HLT icon
179
Hilton Worldwide
HLT
$74B
$1.61M 0.12%
+5,305
New +$1.61M
CF icon
180
CF Industries
CF
$19.2B
$1.6M 0.12%
12,329
-17,961
-59% -$1.83M
BTSG icon
181
BrightSpring Health Services
BTSG
$14.3B
$1.57M 0.12%
+36,797
New +$1.48M
BAH icon
182
Booz Allen Hamilton
BAH
$8.7B
$1.54M 0.11%
19,796
+5,469
+38% +$461K
GEN icon
183
Gen Digital
GEN
$15.6B
$1.54M 0.11%
+82,045
New +$1.9M
ZBH icon
184
Zimmer Biomet
ZBH
$17.7B
$1.52M 0.11%
16,774
+13,299
+383% +$1.22M
ESTC icon
185
Elastic
ESTC
$6.1B
$1.51M 0.11%
+30,186
New +$1.85M
TEVA icon
186
Teva Pharmaceuticals
TEVA
$35.9B
$1.49M 0.11%
49,372
+4,946
+11% +$159K
ARWR icon
187
Arrowhead Research
ARWR
$12.1B
$1.48M 0.11%
23,625
+12,625
+115% +$799K
ABT icon
188
Abbott
ABT
$180B
$1.48M 0.11%
14,448
+3,383
+31% +$382K
KRYS icon
189
Krystal Biotech
KRYS
$9.88B
$1.48M 0.11%
5,732
+3,620
+171% +$963K
ROIV icon
190
Roivant Sciences
ROIV
$25.2B
$1.48M 0.11%
53,409
-10,453
-16% -$269K
IONS icon
191
Ionis Pharmaceuticals
IONS
$9.35B
$1.48M 0.11%
+19,693
New +$1.55M
RVMD icon
192
Revolution Medicines
RVMD
$40.2B
$1.48M 0.11%
15,218
-2,139
-12% -$216K
ALNY icon
193
Alnylam Pharmaceuticals
ALNY
$36.3B
$1.48M 0.11%
4,471
+1,005
+29% +$342K
EQX icon
194
Equinox Gold
EQX
$7.32B
$1.48M 0.11%
102,210
+57,713
+130% +$882K
ABVX
195
Abivax
ABVX
$11B
$1.47M 0.11%
13,186
+5,327
+68% +$630K
TERN
196
DELISTED
Terns Pharmaceuticals
TERN
$1.43M 0.1%
27,120
-6,608
-20% -$271K
XPO icon
197
XPO
XPO
$25B
$1.42M 0.1%
+7,303
New +$1.31M
IBRX icon
198
ImmunityBio
IBRX
$7.44B
$1.42M 0.1%
+185,474
New +$1.27M
RJF icon
199
Raymond James Financial
RJF
$32.5B
$1.42M 0.1%
+9,776
New +$1.55M
GH icon
200
Guardant Health
GH
$19.5B
$1.41M 0.1%
15,217
+7,628
+101% +$766K

Similar funds

FORA Capital's Q1 2026 Portfolio in Review

As of Q1 2026, FORA Capital held 636 positions worth $1.36B, up 65% from $827M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

FORA Capital deployed $603M of net new capital in Q1 2026, opening 225 new positions and adding to 124 existing holdings. Its largest new stake was Barrick Mining: 564,059 shares worth $23M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Sandisk, an estimated $20.2M trimmed.

  • FORA Capital's largest Q1 2026 buy was Barrick Mining: 564,059 shares worth $23M.
  • FORA Capital added most to Boston Scientific in Q1 2026, an estimated $28.7M increase.
  • FORA Capital's biggest Q1 2026 reduction was Sandisk, cutting an estimated $20.2M.
  • FORA Capital fully exited Netflix in Q1 2026, selling an estimated $13.9M.
  • FORA Capital's ten largest holdings make up 17% of its $1.36B portfolio in Q1 2026.
  • FORA Capital opened 225 new positions and closed 223 in Q1 2026.
  • FORA Capital's portfolio value rose 65% quarter-over-quarter to $1.36B.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.